Two decades of #Alzheimer's research may be based on deliberate fraud that has cost millions of lives
https://www.dailykos.com/story/2022/7/22/2111914/-Two-decades-of-Alzheimer-s-research-may-be-based-on-deliberate-fraud-that-has-cost-millions-of-lives
https://wallstreetpro.com/2022/07/23/two-decades-of-alzheimers-research-was-based-on-deliberate-fraud-by-2-scientists-that-has-cost-billions-of-dollars-and-millions-of-lives/
https://www.dailykos.com/story/2022/7/22/2111914/-Two-decades-of-Alzheimer-s-research-may-be-based-on-deliberate-fraud-that-has-cost-millions-of-lives
https://wallstreetpro.com/2022/07/23/two-decades-of-alzheimers-research-was-based-on-deliberate-fraud-by-2-scientists-that-has-cost-billions-of-dollars-and-millions-of-lives/
Daily Kos
Two decades of Alzheimer's research may be based on deliberate fraud that has cost millions of lives
Last month, drug company Genentech reported on the first clinical trials of the drug crenezumab, a drug targeting amyloid proteins that form sticky plaques in the brains of Alzheimer’s disease pati...
Media is too big
VIEW IN TELEGRAM
Corrupt Protectors of Industry: "The Regulatory Agencies Need to Disappear"
"No #aluminum, no #Alzheimer's," argued Del Bigtree, as the regulatory agencies refuse to make a connection.
"Why are they lying to us? Because they're trying to protect the industries that are using aluminum in all sorts of ways ... that is causing this. They're protecting them instead of you. This is the ongoing theme here. The regulatory agencies need to disappear. We need to get rid of them."
Full Episode: https://thehighwire.com/
Follow @VigilantFox 🦊
Rumble | Substack | Support | Socials
"No #aluminum, no #Alzheimer's," argued Del Bigtree, as the regulatory agencies refuse to make a connection.
"Why are they lying to us? Because they're trying to protect the industries that are using aluminum in all sorts of ways ... that is causing this. They're protecting them instead of you. This is the ongoing theme here. The regulatory agencies need to disappear. We need to get rid of them."
Full Episode: https://thehighwire.com/
Follow @VigilantFox 🦊
Rumble | Substack | Support | Socials
Media is too big
VIEW IN TELEGRAM
Three #FDA Advisors Resign over Agency's Approval of Shoddy New #Alzheimer's Drug
In November 2020, an independent panel slammed Aduhelm, a new Alzheimer's drug just approved by the FDA. When asked if there was supportive evidence for the use of this drug, zero out of the seven panel members said yes.
"The drug, Aduhelm, a monthly infusion priced at $56,000 per year, was approved this week despite weak evidence that it helps patients," reported The New York Times.
Full Episode: https://thehighwire.com
Follow @VigilantFox 🦊
Rumble | Substack | Support | Socials
In November 2020, an independent panel slammed Aduhelm, a new Alzheimer's drug just approved by the FDA. When asked if there was supportive evidence for the use of this drug, zero out of the seven panel members said yes.
"The drug, Aduhelm, a monthly infusion priced at $56,000 per year, was approved this week despite weak evidence that it helps patients," reported The New York Times.
Full Episode: https://thehighwire.com
Follow @VigilantFox 🦊
Rumble | Substack | Support | Socials